Cynthia Gagnon

Financement

• Subvention. Performing a Rare Disease-Oriented Master Observational Trial to decipher complexity and optimize trial readiness; PROMOTE network. Swiss National Science Foundation (Bern, Suisse). 243 986 CHF. (2024-2027).
  Numéro de subvention : 219143. Voir plus
• Subvention. Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs. Canadian Institutes of Health Research (Ottawa, Canada). 1 597 256 $. (2024-2028).
  Numéro de subvention : 202311IHA. Voir plus
• Subvention. Performing a Rare disease-Oriented Master Observational Trial to decipher complexity and optimize trial readiness. Canadian Institutes of Health Research (Ottawa, Canada). 448 853 $. (2024-2026).
  Numéro de subvention : 202306ERT. Voir plus
• Subvention. NMD4C: the neuromuscular network for Canada. Canadian Institutes of Health Research (Ottawa, Canada). 1 000 000 $. (2023-2028).
  Numéro de subvention : 202301OR2. Voir plus
• Subvention. IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial. Canadian Institutes of Health Research (Ottawa, Canada). 638 776 $. (2023-2027).
  Numéro de subvention : 202209PJT. Voir plus
• Subvention. A comprehensive study of the natural history of OPMD: An essential step towards clinical trial readiness and evidence-based interventions. Canadian Institutes of Health Research (Ottawa, Canada). 820 846 $. (2021-2026).
  Numéro de subvention : 202104PJT. Voir plus
• Subvention. Plateforme intégrée d’innovations technologiques et d’application des connaissances en santé génétique (PI2TAC). Canada Foundation for Innovation (Ottawa, Canada). 320 100 $. (2021).
  Numéro de subvention : 40836. Voir plus
• Subvention. NMD4C: An integrated research network for patients, scientists, and clinicians to improve outcomes and access to therapies for patients with neuromuscular disorders in Canada. Canadian Institutes of Health Research (Ottawa, Canada). 620 852 $. (2020-2022).
  Numéro de subvention : 201908NG2. Voir plus
• Subvention. PROSPAX: an integrated multimodal progression chart in spastic ataxias. Canadian Institutes of Health Research (Ottawa, Canada). 224 436 $. (2020-2022).
  Numéro de subvention : 201906ERT. Voir plus
• Subvention. Comprendre l'Histoire naturelle pour mieux Orienter les Interventions et Services et la planification des essais thérapeutiques pour les personnes atteintes de Maladies NeuroMusculaires (CHOIS-MNM). Fonds de Recherche du Québec - Santé (Montreal, Canada). 286 529 $. (2019-2023).
  Numéro de subvention : 267824. Voir plus
• Subvention. A comprehensive study of the natural history of ARSACS: An essential step towards clinical trial readiness and evidence-based interventions. Canadian Institutes of Health Research (Ottawa, Canada). 584 785 $. (2018-2022).
  Numéro de subvention : 201803PJT. Voir plus
• Subvention. Comprendre l'Histoire naturelle pour mieux Orienter les Interventions et Services et la planification des essais thérapeutiques pour les personnes atteintes de Maladies NeuroMusculaires (CHOIS-MNM). Fonds de Recherche du Québec - Santé (Montreal, Canada). 338 773 $. (2015-2019).
  Numéro de subvention : 31011. Voir plus
• Subvention. The Canadian Neuromuscular Network (CAN-NMD). Canadian Institutes of Health Research (Ottawa, Canada). 575 614 $. (2014-2017).
  Numéro de subvention : 201311NCT. Voir plus
• Subvention. Déterminants et impacts de la durée de séjour et de l'intensité des soins en neurotraumatologie : revue systématique de la littérature. Fonds de Recherche du Québec - Santé (Montreal, Canada). 49 540 $. (2012-2013).
  Numéro de subvention : 26653. Voir plus
• Subvention. New emerging team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies. Canadian Institutes of Health Research (Ottawa, Canada). 2 500 000 $. (2012-2017).
  Numéro de subvention : 201108TR2. Voir plus
• Subvention. Améliorer le suivi des maladies neuromusculaires par une démarche systématique : caractérisation, interventions et évaluation des résultats dans la dystrophie myotonique. Fonds de Recherche du Québec - Santé (Montreal, Canada). 45 000 $. (2011-2014).
  Numéro de subvention : 24437. Voir plus
• Subvention. Améliorer le suivi des maladies neuromusculaires par une démarche systématique : caractérisation, interventions et évaluation des résultats dans la dystrophie myotonique. Fonds de Recherche du Québec - Santé (Montreal, Canada). 316 199 $. (2011-2015).
  Numéro de subvention : 22193. Voir plus
• Subvention. Motor, multisystemic and social participation assessment in myotonic dystrophy type 1: a 9-year longitudinal study. Canadian Institutes of Health Research (Ottawa, Canada). 170 223 $. (2010-2013).
  Numéro de subvention : 201003JNM. Voir plus
• Subvention. Organisation des services pour les maladies neuromusculaires: Constats, enjeux et priorites. Canadian Institutes of Health Research (Ottawa, Canada). 14 985 $. (2009).
  Numéro de subvention : 200810MPS. Voir plus
• Subvention. Processus d'implantation et efficacite d'un plan de soins integres pour les maladies complexes: illustration chez une population atteinte de dystrophie myotonique. Canadian Institutes of Health Research (Ottawa, Canada). 190 000 $. (2007-2010).
  Numéro de subvention : 200602MFE. Voir plus
• Subvention. Innovative model for delivery of care for myotonic dystrophy type 1: Elaboration, validation and implementation of an integrated care pathway. Canadian Institutes of Health Research (Ottawa, Canada). 160 000 $. (2005-2008).
  Numéro de subvention : 200505PHE. Voir plus
• Subvention. Consequences fonctionnelles et sociales de la dystrophie myotonique : Impact des facteurs personnels et environnementaux sur la participation sociale. Canadian Institutes of Health Research (Ottawa, Canada). 135 000 $. (2004-2006).
  Numéro de subvention : 200310GPF. Voir plus
• Subvention. Consequences fonctionnelles et sociales de la dystrophie myotonique : Impact des facteurs personnels et environnementaux sur la participation sociale. Canadian Institutes of Health Research (Ottawa, Canada). 41 500 $. (2003).
  Numéro de subvention : 200111MIG. Voir plus

Publications

Articles

• Cécile Di Folco, Charlotte Dubec‐Fleury, Andreas Traschütz, Christoph Kessler, Selina Reich, Cynthia Gagnon, Isabelle Lessard, Xavier Rodrigue, Sirio Cocozza, Sara Satolli, Filippo M. Santorelli, Alexandra Durr, Anna Heinzmann, Bart P. van de Warrenburg, Ilse H.J. Willemse, A. Nazli Başak, Atay Vural, Bernard Brais, Stephan Klebe, ... Sophie Tezenas du Montcel. (2025). Spastic Ataxia Composite (SPAXCOM): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia. Movement Disorders. DOI
• Alyssa Grant, Ian C. Smith, Lola E.R. Lessard, Homira Osman, Hanns Lochmuller, Hugh J. McMillan, Gerald Pfeffer, Lawrence Korngut, Cynthia Gagnon, Stacey Lintern, Kathryn A. Selby, Kednapa Thavorn, Jodi Warman-Chardon. (2025). Financial Toxicity and Its Determinants in Individuals Living With Inherited and Acquired Neuromuscular Disorders. Neurology. DOI
• Ian C. Smith, Yasmin Abusetah, Homira Osman, Aditi Garg, Alyssa Grant, Hanns Lochmuller, Hugh McMillan, Gerald Pfeffer, Lawrence Korngut, Cynthia Gagnon, Stacey Lintern, Daria Wojtal, Kathy Selby, Kednapa Thavorn, Jodi Warman-Chardon. (2025). Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocol. Orphanet Journal of Rare Diseases. DOI
• Ernest Niyomwungere, François Routhier, Cynthia Gagnon, R Lee Kirby, Xavier Rodrigue, Isabelle Lessard, Josiane Lettre, Krista L Best. (2025). Efficacy of Manual Wheelchair Skills Training for Improving Skills and Confidence in People With Hereditary Degenerative Disorders: Protocol for a Sequential Multimethods Study. JMIR Research Protocols. DOI
• Samar Muslemani, Jean-Denis Brisson, Isabelle Côté, Isabelle Lessard, Claudia Côté, Bernard Brais, Cynthia Gagnon. (2025). Social Participation Restrictions and Explanatory Factors in Adults with Oculopharyngeal Muscular Dystrophy. Canadian Journal of Occupational Therapy. DOI
• Lukas Beichert, Winfried Ilg, Christoph Kessler, Andreas Traschütz, Selina Reich, Filippo M. Santorelli, Ayşe Nazli Başak, Cynthia Gagnon, Rebecca Schüle, Matthis Synofzik. (2024). Digital Gait Outcomes for Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay (ARSACS): Discriminative, Convergent, and Ecological Validity in a Multicenter Study (PROSPAX). Movement Disorders. DOI
• Marie-Pier Roussel, Aymeric Ravel-Chapuis, Jonathan Gobin, Bernard J. Jasmin, Jean-Philippe Leduc-Gaudet, Cynthia Gagnon, Elise Duchesne. (2024). Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study. Journal of Neuromuscular Diseases. DOI
• Jean‐Denis Brisson, Bernard Brais, Jean Mathieu, Isabelle Lessard, Valérie Gagné‐Ouellet, Isabelle Côté, Cynthia Gagnon. (2023). Characterization of muscle strength and mobility in oculopharyngeal muscular dystrophy. Muscle & Nerve. DOI
• Andreas Traschütz, Astrid D. Adarmes‐Gómez, Mathieu Anheim, Jonathan Baets, Bernard Brais, Cynthia Gagnon, Janina Gburek‐Augustat, Sarah Doss, Haşmet A. Hanağası, Christoph Kamm, Peter Klivenyi, Thomas Klockgether, Thomas Klopstock, Martina Minnerop, Alexander Münchau, Mathilde Renaud, Filippo M. Santorelli, Ludger Schöls, Andreas Thieme, ... Matthis Synofzik. (2023). Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients. Annals of Neurology. DOI
• Julie Bourassa, François Routhier, Cynthia Gagnon, Caroline Rahn, Luc J. Hébert, Raphaël St-Gelais, Xavier Rodrigue, Bernard Brais, Krista L. Best. (2023). Wheelchair mobility, motor performance and participation of adult wheelchair users with ARSACS: a cross-sectional study. Disability and Rehabilitation: Assistive Technology. DOI
• Jacques Cherblanc, Cynthia Gagnon, Isabelle Côté, Christiane Bergeron-Leclerc, Susan Cadell, Geneviève Gauthier, Paul A. Boelen. (2023). French-Canadian validation of the Traumatic Grief Inventory-Self Report (TGI-SR). Death Studies. DOI
• Julie Bourassa, Krista L. Best, Cynthia Gagnon, Luc J. Hébert, Bernard Brais, François Routhier. (2022). Measurement properties of wheelchair use assessment tools in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay. Disability and Rehabilitation: Assistive Technology. DOI
• Dax Bourcier, Nicolas Bélair, Élyse-Anne Pedneault-Tremblay, Isabelle Lessard, Thomas Klockgether, Matthis Synofzik, Caroline Rahn, Bernard Brais, Elise Duchesne, Cynthia Gagnon. (2022). French Translation and Cross-cultural Adaptation of the Scale for the Assessment and Rating of Ataxia. The Cerebellum. DOI
• Kateri Raymond, Mélanie Levasseur, Benjamin Gallais, Louis Richer, Luc Laberge, Émilie Petitclerc, Jean Mathieu, Cynthia Gagnon. (2022). Predictors of participation restriction over a 9-year period in adults with myotonic dystrophy type 1. Disability and Rehabilitation. DOI
• Isabelle Lessard, Raphaël St-Gelais, Luc J. Hébert, Isabelle Côté, Jean Mathieu, Bernard Brais, Cynthia Gagnon. (2021). Functional mobility in walking adult population with ataxia of Charlevoix-Saguenay. Orphanet Journal of Rare Diseases. DOI
• Marie-Pier Roussel, Marie-Michèle Fiset, Laurie Gauthier, Claudia Lavoie, Émilie McNicoll, Laurie Pouliot, Cynthia Gagnon, Elise Duchesne. (2021). Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study. Journal of Neurology. DOI
• Kevin Chapron, Patrick Lapointe, Isabelle Lessard, Hans Darsmstadt-Belanger, Kevin Bouchard, Cynthia Gagnon, Melissa Lavoie, Elise Duchesne, Sebastien Gaboury. (2021). Acti-DM1: Monitoring the Activity Level of People With Myotonic Dystrophy Type 1 Through Activity and Exercise Recognition. IEEE Access. DOI
• Cynthia Gagnon, Benjamin Gallais. (2020). Understanding factors hampering activities of daily living performance in childhood‐onset myotonic dystrophy phenotypes. Developmental Medicine & Child Neurology. DOI
• Kateri Raymond, Mélanie Levasseur, Jean Mathieu, Cynthia Gagnon. (2019). Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1. Archives of Physical Medicine and Rehabilitation. DOI
• Marie-Michèle Briand, Xavier Rodrigue, Isabelle Lessard, Jean Mathieu, Bernard Brais, Isabelle Côté, Cynthia Gagnon. (2019). Expanding the clinical description of autosomal recessive spastic ataxia of Charlevoix-Saguenay. Journal of the Neurological Sciences. DOI
• Overend, G., Legare, C., Mathieu, J., Bouchard, L., Gagnon, C., Monckton, D.G. (2019). Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Human Molecular Genetics. DOI
• Côté, C., Germain, I., Dufresne, T., Gagnon, C. (2019). Comparison of two methods to categorize thickened liquids for dysphagia management in a clinical care setting context: The Bostwick consistometer and the IDDSI Flow Test. Are we talking about the same concept?. Journal of Texture Studies. DOI
• Roussel, M.-P., Morin, M., Gagnon, C., Duchesne, E. (2019). Correction: What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review (BMC Musculoskeletal Disorders (2019) 20 (101) DOI: 10.1186/s12891-019-2458-7). BMC Musculoskeletal Disorders. DOI
• Légaré, C., Overend, G., Guay, S.-P., Monckton, D.G., Mathieu, J., Gagnon, C., Bouchard, L. (2019). DMPK gene DNA methylation levels are associated with muscular and respiratory profiles in DM1. Neurology: Genetics. DOI
• Gagnon, C., Brais, B., Lessard, I., Lavoie, C., Côté, I., Mathieu, J. (2019). Development and validation of a disease severity index for ataxia of Charlevoix-Saguenay. Neurology. DOI
• Laberge, L., Gallais, B., Auclair, J., Dauvilliers, Y., Mathieu, J., Gagnon, C. (2019). Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1. Journal of Neurology. DOI
• De Antonio, M., Dogan, C., Daidj, F., Eymard, B., Puymirat, J., Mathieu, J., Gagnon, C., Katsahian, S., Arne Bes, M.C., Attarian, S., Aube-Nathier, A.-C., Audic, F., Bach, N., Barnerias, C., Bedat-Millet, A.-L., Behin, A., Bellance, R., Benyaou, R., Bombard, V., ... Bassez, G. (2019). The DM-scope registry: A rare disease innovative framework bridging the gap between research and medical care. Orphanet Journal of Rare Diseases. DOI
• Côté, C., Gagnon, C., Youssof, S., sKurtz, N., Brais, B. (2019). The requirement for a disease-specific patient-reported outcome measure of dysphagia in oculopharyngeal muscular dystrophy. Muscle and Nerve. DOI
• Roussel, M.-P., Morin, M., Girardin, M., Fortin, A.-M., Leone, M., Mathieu, J., Gagnon, C., Duchesne, E. (2019). Training program-induced skeletal muscle adaptations in two men with myotonic dystrophy type 1. BMC Research Notes. DOI
• Roussel, M.-P., Morin, M., Gagnon, C., Duchesne, E. (2019). What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review. BMC Musculoskeletal Disorders. DOI
• Cynthia Gagnon, Bernard Brais, Isabelle Lessard, Caroline Lavoie, Isabelle Côté, Jean Mathieu. (2018). From motor performance to participation: a quantitative descriptive study in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay. Orphanet Journal of Rare Diseases. DOI
• Cynthia Gagnon, Isabelle Lessard, Bernard Brais, Isabelle Côté, Caroline Lavoie, Matthis Synofzik, Jean Mathieu. (2018). Validity and Reliability of Outcome Measures Assessing Dexterity, Coordination, and Upper Limb Strength in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay. Archives of Physical Medicine and Rehabilitation. DOI
• Cynthia Gagnon, Émilie Petitclerc, Marie Kierkegaard, Jean Mathieu, Élise Duchesne, Luc J. Hébert. (2018). A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1. Journal of Neurology. DOI
• Isabelle Lessard, Bernard Brais, Isabelle Côté, Caroline Lavoie, Matthis Synofzik, Jean Mathieu, Cynthia Gagnon. (2018). Assessing mobility and balance in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay population: Validity and reliability of four outcome measures. Journal of the Neurological Sciences. DOI
• Wood, L., Bassez, G., van Engelen, B., Lochmüller, H., Schoser, B., Atalaia, A., Balabanov, P., Boentert, M., Charlton, J., Gagnon, C., Geille, A., Heatwole, C., Heerschap, A., Kierkegaard, M., Kornblum, C., Lindberg, C., Meola, G., Mignon, L., Monckton, D., ... Vissing, J. (2018). 222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1–2 July 2016. Neuromuscular Disorders. DOI
• Gagnon, C., Lessard, I., Lavoie, C., Cote, I., St-Gelais, R., Mathieu, J., Brais, B. (2018). Article an exploratory natural history of ataxia of charlevoix-saguenay a 2-year follow-up. Neurology. DOI
• Ashizawa, T., Gagnon, C., Groh, W.J., Gutmann, L., Johnson, N.E., Meola, G., Moxley, R., Pandya, S., Rogers, M.T., Simpson, E., Angeard, N., Bassez, G., Berggren, K.N., Bhakta, D., Bozzali, M., Broderick, A., Byrne, J.L.B., Campbell, C., Cup, E., ... Winblad, S. (2018). Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurology: Clinical Practice. DOI
• Vogel, A.P., Rommel, N., Oettinger, A., Stoll, L.H., Kraus, E.-M., Gagnon, C., Horger, M., Krumm, P., Timmann, D., Storey, E., Schöls, L., Synofzik, M. (2018). Coordination and timing deficits in speech and swallowing in autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS). Journal of Neurology. DOI
• Côté, C., Gagnon, C., Payette, H. (2018). French cross-cultural adaptation of the Edinburgh Feeding Evaluation in Dementia (EdFED) Scale: A questionnaire to assess feeding difficulties among elderly people with cognitive problems in residential centers,Adaptation transculturelle en français du Edinburgh Feeding Evaluation in Dementia (EdFED) Scale : Un questionnaire pour évaluer les difficultés à s'alimenter de personnes âgées présentant des troubles cognitifs en centre d'hébergement. Canadian Journal on Aging. DOI
• Gagnon, C., Tremblay, M., CôTé, I., Heatwole, C. (2018). French translation and cross-cultural adaptation of The Myotonic Dystrophy Health Index. Muscle and Nerve. DOI
• Gagnon, C., Gallais, B., Laberge, L. (2018). Myotonic dystrophy type 1: reasons to be OPTIMISTIC. The Lancet Neurology. DOI
• Elfassy, C., Darsaklis, V.B., Snider, L., Gagnon, C., Hamdy, R., Dahan-Oliel, N. (2018). Rehabilitation needs of youth with arthrogryposis multiplex congenita: Perspectives from key stakeholders. Disability and Rehabilitation. DOI
• Petitclerc, E., Hébert, L.J., Mathieu, J., Desrosiers, J., Gagnon, C. (2018). Relationships between lower limb muscle strength impairments and physical limitations in DM1. Journal of Neuromuscular Diseases. DOI
• Gallais, B., Gagnon, C., Côté, I., Forgues, G., Laberge, L. (2018). Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1. Journal of Neuromuscular Diseases. DOI
• Gagnon, C., Heatwole, C., Hébert, L.J., Hogrel, J.-Y., Laberge, L., Leone, M., Meola, G., Richer, L., Sansone, V., Kierkegaard, M. (2018). Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. Journal of Neuromuscular Diseases. DOI
• Kierkegaard, M., Petitclerc, É., Hébert, L.J., Mathieu, J., Gagnon, C. (2018). Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1. Journal of Rehabilitation Medicine. DOI
• Isabelle Lessard, Caroline Lavoie, Isabelle Côté, Jean Mathieu, Bernard Brais, Cynthia Gagnon. (2017). Validity and reliability of the LEMOCOT in the adult ARSACS population: A measure of lower limb coordination. Journal of the Neurological Sciences. DOI
• Benjamin Gallais, Cynthia Gagnon, Geneviève Forgues, Isabelle Côté, Luc Laberge. (2017). Further evidence for the reliability and validity of the Fatigue and Daytime Sleepiness Scale. Journal of the Neurological Sciences. DOI
• Raymond, K., Levasseur, M., Mathieu, J., Desrosiers, J., Gagnon, C. (2017). A 9-year follow-up study of the natural progression of upper limb performance in myotonic dystrophy type 1: A similar decline for phenotypes but not for gender. Neuromuscular Disorders. DOI
• Renaud, M., Tranchant, C., Martin, J.V.T., Mochel, F., Synofzik, M., van de Warrenburg, B., Pandolfo, M., Koenig, M., Kolb, S.A., Anheim, M., Alonso, I., Azzedine, H., Barbot, C., Bereau, M., Berkovic, S., Bernard, G., Bindoff, L.A., Bompaire, F., Bonneau, D., ... Young, M. (2017). A recessive ataxia diagnosis algorithm for the next generation sequencing era. Annals of Neurology. DOI
• Gallais, B., Gagnon, C., Mathieu, J., Richer, L. (2017). Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study. Neuromuscular Disorders. DOI
• Bui, H.T., Audet, O., Mathieu, J., Gagnon, C., Leone, M. (2017). Computer-based assessment of upper-limb incoordination in autosomal recessive spastic ataxia of Charlevoix-Saguenay patients: A pilot study. Journal of the Neurological Sciences. DOI
• Barbé, L., Lanni, S., López-Castel, A., Franck, S., Spits, C., Keymolen, K., Seneca, S., Tomé, S., Miron, I., Letourneau, J., Liang, M., Choufani, S., Weksberg, R., Wilson, M.D., Sedlacek, Z., Gagnon, C., Musova, Z., Chitayat, D., Shannon, P., ... Pearson, C.E. (2017). CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy. American Journal of Human Genetics. DOI
• Bonnemann, C., Boutin, M., Brais, B., Buccella, F., Burghes, A., Coffey, C., Dasgupta, N., Dawkins, H., De Luca, A., Dowd, C., Duong, T., Eagle, M., Finkel, R., Furlong, P., Gagnon, C., Goemans, N., Guglieri, M., Hathout, Y., Johnson, N., ... Willmann, R. (2017). Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA. Neuromuscular Disorders. DOI
• Kierkegaard, M., Petitclerc, E., Hébert, L.J., Gagnon, C. (2017). Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1. Neuromuscular Disorders. DOI
• Petitclerc, É., Hébert, L.J., Mathieu, J., Desrosiers, J., Gagnon, C. (2017). Lower limb muscle strength impairment in late-onset and adult myotonic dystrophy type 1 phenotypes. Muscle and Nerve. DOI
• Bui, H.T., Gagnon, C., Audet, O., Mathieu, J., Leone, M. (2017). Measurement properties of a new wireless electrogoniometer for quantifying spasticity during the pendulum test in ARSACS patients. Journal of the Neurological Sciences. DOI
• Gagnon, C., Kierkegaard, M., Blackburn, C., Chrestian, N., Lavoie, M., Bouchard, M.-F., Mathieu, J. (2017). Participation restriction in childhood phenotype of myotonic dystrophy type 1: a systematic retrospective chart review. Developmental Medicine and Child Neurology. DOI
• Hesterlee, S., Amur, S., Bain, L.J., Carulli, J., Clarke, S., Day, J.W., Gagnon, C., Hagerman, K., Heatwole, C., Johnson, N.E., Moxley, R., Patel, N., Thornton, C., Kessel, W., White, M. (2017). Patient-Centered Therapy Development for Myotonic Dystrophy: Report of the Myotonic Dystrophy Foundation–Sponsored Workshop. Therapeutic Innovation and Regulatory Science. DOI
• Côté, C., Payette, H., Gagnon, C. (2017). Prévenir la dénutrition des personnes âgées dysphagiques institutionnalisées avec une alimentation à textures adaptées: essai clinique randomisé. Canadian Journal of Dietetic Practice and Research. DOI
• Gagnon, C., Massie, R., Tremblay, M., Darcy, S., Martel, M., Burns, J. (2017). Traduction française de l'échelle Charcot-Marie-Tooth disease pediatric scale. Canadian Journal of Neurological Sciences. DOI
• Raymond, K., Levasseur, M., Chouinard, M.-C., Mathieu, J., Gagnon, C. (2016). Stanford Chronic Disease Self-Management Program in myotonic dystrophy: New opportunities for occupational therapists. Canadian Journal of Occupational Therapy. DOI
• Sansone, V.A., Gagnon, C., Atalaia , A., Boentert, M., Duboc, D., Falcier, E., Gallais, B., Heatwole, C., Iatomasi, M., Orlikowski, D., Phillips, M., Rao, F., Rogers, M., Schoser, B., Wijkstra, P. (2015). 207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: Management and implications for research, 27-29 June 2014, Naarden, The Netherlands. Neuromuscular Disorders. DOI
• Chouinard, M.-C., Lavoie, M., Gagnon, C., Leclerc, N., Larouche, A., Bouchard, N., Lafleur, G. (2015). A neuromuscular disease clinical model,Un modèle en clinique de maladies neuromusculaires. Perspective infirmière : revue officielle de l'Ordre des infirmières et infirmiers du Québec.
• Raymond, K., Auger, L.-P., Cormier, M.-F., Vachon, C., St-Onge, S., Mathieu, J., Noreau, L., Gagnon, C. (2015). Assessing upper extremity capacity as a potential indicator of needs related to household activities for rehabilitation services in people with myotonic dystrophy type 1. Neuromuscular Disorders. DOI
• Petitclerc, E., Hébert, L.J., Desrosiers, J., Gagnon, C. (2015). Lower limb muscle impairment in myotonic dystrophy type 1: The need for better guidelines. Muscle and Nerve. DOI
• Gallais, B., Montreuil, M., Gargiulo, M., Eymard, B., Gagnon, C., Laberge, L. (2015). Prevalence and correlates of apathy in myotonic dystrophy type 1. BMC Neurology. DOI
• Bertrand, J.A., Jean, S., Laberge, L., Gagnon, C., Mathieu, J., Gagnon, J.F., Richer, L. (2015). Psychological characteristics of patients with myotonic dystrophy type 1. Acta Neurologica Scandinavica. DOI
• Gagnon, C., Meola, G., Hébert, L.J., Laberge, L., Leone, M., Heatwole, C. (2015). Report of the second Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-2) international workshop San Sebastian, Spain, October 16, 2013. Neuromuscular Disorders. DOI
• Gallais, B., Gagnon, C., Mathieu, J., Richer, L., Jean, S., Laberge, L. (2014). Cognitive deficits associated with sleep apnea in myotonic dystrophy type 1. Journal of Neuromuscular Diseases. DOI
• Bugiardini, E., Meola, G., Alvarez, C., Angeard, N., Bassez, G., Day, J.W., Dent, G., Ekström, A.-B., Eymard, B., Fossati, B., Gagnon, C., Gomes-Pereira, M., Gourdon, G., Heatwole, C., Housman, D.E., Johnson, N.E., Kornblum, C., MacKenzie, D., Minnerop, M., ... Ladd, A. (2014). Consensus on cerebral involvement in myotonic dystrophy. Workshop report: May 24-27, 2013, Ferrere (AT), Italy. Neuromuscular Disorders. DOI
• Gagnon, C., Lavoie, C., Lessard, I., Mathieu, J., Brais, B., Bouchard, J.-P., Fluet, M.-C., Gassert, R., Lambercy, O. (2014). The Virtual Peg Insertion Test as an assessment of upper limb coordination in ARSACS patients: A pilot study. Journal of the Neurological Sciences. DOI
• Laberge, L., Mathieu, J., Auclair, J., Gagnon, E., Noreau, L., Gagnon, C. (2013). Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. European Neurology. DOI
• Laberge, L., Gagnon, C., Dauvilliers, Y. (2013). Daytime sleepiness and myotonic dystrophy. Current Neurology and Neuroscience Reports. DOI
• Fortin, M., Chouinard, M.-C., Bouhali, T., Dubois, M.-F., Gagnon, C., Bélanger, M. (2013). Evaluating the integration of chronic disease prevention and management services into primary health care. BMC Health Services Research. DOI
• Gagnon, C., Chouinard, M.-C., Laberge, L., Brisson, D., Gaudet, D., Lavoie, M., Leclerc, N., Mathieu, J. (2013). Prevalence of lifestyle risk factors in myotonic dystrophy type 1. Canadian Journal of Neurological Sciences. DOI
• Gagnon, C., Meola, G., Hébert, L.J., Puymirat, J., Laberge, L., Leone, M. (2013). Report of the first Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-1) international workshop. Clearwater, Florida, November 30, 2011. Neuromuscular Disorders. DOI
• Gagnon, C., Aimé, A., Bélanger, C., Markowitz, J.T. (2012). Comorbid Diabetes and Eating Disorders in Adult Patients: Assessment and Considerations for Treatment. The Diabetes Educator. DOI
• Rouleau, A., Bélanger, C., O'Connor, K., Gagnon, C. (2011). Evaluation of inappropriate benzodiazepine use among the elderly: Risk factors and impacts,Évaluation de l'usage à risque des benzodiazépines chez les personnes âgées: Facteurs de risque et impacts. Sante Mentale au Quebec. DOI
• Gagnon, C., Chouinard, M.C., Laberge, L., Veillette, S., Bégin, P., Breton, R., Jean, S., Brisson, D., Gaudet, D., Mathieu, J. (2010). Health supervision and anticipatory guidance in adult myotonic dystrophy type 1. Neuromuscular Disorders. DOI
• Gagnon, C., Chouinard, M.C., Lavoie, M., Champagne, F. (2010). [Analysis of the nursing role in the care of patients with neuromuscular disorders].,Analyse du rô1e de l'infirmière dans le suivi des personnes atteintes de maladies neuromusculaires. Canadian journal of neuroscience nursing.
• Chouinard, M.-C., Gagnon, C., Laberge, L., Tremblay, C., Côté, C., Ledere, N., Mathieu, J. (2009). The potential of disease management for neuromuscular hereditary disorders. Rehabilitation Nursing. DOI
• Gagnon, C., Mathieu, J., Jean, S., Laberge, L., Perron, M., Veillette, S., Richer, L., Noreau, L. (2008). Predictors of Disrupted Social Participation in Myotonic Dystrophy Type 1. Archives of Physical Medicine and Rehabilitation. DOI
• Gagnon, C., Mathieu, J., Noreau, L. (2007). Life habits in myotonic dystrophy type 1. Journal of Rehabilitation Medicine. DOI
• Gagnon, C., Noreau, L., Moxley, R.T., Laberge, L., Jean, S., Richer, L., Perron, M., Veillette, S., Mathieu, J. (2007). Towards an integrative approach to the management of myotonic dystrophy type 1. Journal of Neurology, Neurosurgery and Psychiatry. DOI
• Gagnon, C., Mathieu, J., Noreau, L. (2006). Measurement of participation in myotonic dystrophy: Reliability of the LIFE-H. Neuromuscular Disorders. DOI
• Laberge, L., Gagnon, C., Jean, S., Mathieu, J. (2005). Fatigue and daytime sleepiness rating scales in myotonic dystrophy: A study of reliability. Journal of Neurology, Neurosurgery and Psychiatry. DOI
• Gagnon, C., Desrosiers, J., Mathieu, J. (2004). Autosomal recessive spastic ataxia of Charlevoix-Saguenay: Upper extremity aptitudes, functional independence and social participation. International Journal of Rehabilitation Research. DOI
• Gagnon, C., Mathieu, J., Desrosiers, J. (2004). Standardized finger-nose test validity for coordination assessment in an ataxic disorder. Canadian Journal of Neurological Sciences. DOI

Articles de conférence

• Killian Lachaux, Élodie Gagnon, Florentin Thullier, Claudia Maltais, Julien Maitre, Kévin Bouchard, Cynthia Gagnon, Élise Duchesne, Sébastien Gaboury. (2024). Preparing for the Clinical Stage : Lab Development and Testing of Socially Assistive Robot for Physical Health Assessments. DOI

Autres contributions

Divers

• Isabelle Lessard, Raphaël St-gelais, Luc J Hébert, Isabelle Coté, Jean Mathieu, Bernard Brais, Cynthia Gagnon. (2021). Functional Mobility in Walking Adult Population With Ataxia of Charlevoix-Saguenay.
• Lamontagne, M.E., Gagnon, C., Allaire, A.S., Noreau, L. (2013). Effect of rehabilitation length of stay on outcomes in individuals with traumatic brain injury or spinal cord injury: a systematic review protocol. Systematic reviews.